A Breakthrough in Cancer Detection and Treatment
SDV Medical is committed to providing healthcare professionals with cutting-edge solutions that improve patient care. One of the most exciting advancements in oncology is Circulogene’s liquid biopsy blood test, a non-invasive, highly accurate method for detecting and monitoring cancer. This innovative test uses a simple blood draw to analyze circulating tumor DNA (ctDNA), allowing for earlier detection, personalized treatment, and real-time monitoring of disease progression.
How It Works
Circulogene’s liquid biopsy technology enables rapid and precise genetic profiling of cancer without the need for invasive tissue biopsies. A standard blood draw is performed, offering a quick and painless experience for patients. Circulogene’s proprietary technology then enhances the recovery of ctDNA, even in small amounts, and next-generation sequencing (NGS) detects genetic mutations associated with cancer. The results provide clinicians with a detailed analysis, guiding personalized treatment decisions and improving patient outcomes.
The Advantages of Liquid Biopsy
Unlike traditional tissue biopsies, which require surgical procedures, liquid biopsies provide a less invasive, more efficient alternative. The test delivers results in just a few days, allowing oncologists to make quicker, data-driven treatment decisions. By identifying specific genetic mutations, Circulogene’s technology enables personalized treatment selection, ensuring patients receive the most effective therapies. Additionally, liquid biopsy allows for ongoing monitoring of disease progression, detecting emerging resistance mutations and potential cancer recurrence before symptoms appear.
Key benefits of Circulogene’s liquid biopsy include:
Non-invasive testing – A simple blood draw replaces the need for surgical biopsies.
Faster results – Clinicians receive actionable data in days rather than weeks.
Personalized treatment insights – Helps match patients with the most effective therapies.